Ipsen Biopharma
ONIVYDE
Manufacturer:
Ipsen Biopharma
Name:
ONIVYDE
HCPCS Code Descriptor:
Injection, irinotecan liposome, 1 mg
Category:
J Code
HCPCS:
J9205
NDC(s):
15054-0043-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ONIVYDE is an Oncology drug manufactured by Ipsen Biopharma and administered via the Intravenous route of administration. The J Code: J9205 is aligned to the drug ONIVYDE.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/17
HCPCS Effective Date:
1/1/17
HCPCS Short Description:
Inj irinotecan liposome 1 mg
Billing and Coding Guide:
https://www.onivyde.com/sites/g/files/kcxpwu251/files/2022-09/ONV-US-003065-Onivyde-Resource-Guide-electronic.pdf
Patient Assistance:
http://www.ipsencares.com/